# PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study

> **NCT05681689** · PHASE3 · RECRUITING · sponsor: **ARJ Medical, Inc.** · enrollment: 77 (estimated)

## Conditions studied

- Helicobacter Pylori Infection
- Post-Treatment
- Efficacy

## Interventions

- **COMBINATION_PRODUCT:** PyloPlus UBT System
- **DIAGNOSTIC_TEST:** Histology
- **DIAGNOSTIC_TEST:** Rapid Urease Test
- **COMBINATION_PRODUCT:** Comparator Breath Test
- **DIAGNOSTIC_TEST:** Stool Antigen Test

## Key facts

- **NCT ID:** NCT05681689
- **Lead sponsor:** ARJ Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-21
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05681689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05681689, "PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05681689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*